These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 206516)

  • 1. Specificity studies of leukocytic catecholamine receptors.
    Sokol WN; Beall GN; Kruger SR
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):173-6. PubMed ID: 206516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the human platelet alpha-adrenergic receptor. Correlation of [3H]dihydroergocryptine binding with aggregation and adenylate cyclase inhibition.
    Alexander RW; Cooper B; Handin RI
    J Clin Invest; 1978 May; 61(5):1136-44. PubMed ID: 207726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE; Stump DC
    Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenyl cyclase in human leukocytes: evidence for activation by separate beta adrenergic and prostaglandin receptors.
    Bourne HR; Melmon KL
    J Pharmacol Exp Ther; 1971 Jul; 178(1):1-7. PubMed ID: 4325858
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in responsiveness of the beta-adrenergic and serotonergic pathways of the rabbit corneal epithelium.
    Neufeld AH; Ledgard SE; Yoza BK
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):527-34. PubMed ID: 6132896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catecholamine binding to CNS adrenergic receptors.
    U'Prichard DC; Snyder SH
    J Supramol Struct; 1978; 9(2):189-206. PubMed ID: 219293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsensitivity of adenylyl cyclase-coupled receptors on mononuclear leukocytes from drug-free inpatients with a major depressive episode.
    Mann JJ; Halper JP; Wilner PJ; Sweeney JA; Mieczkowski TA; Chen JS; Stokes PE; Brown RP
    Biol Psychiatry; 1997 Nov; 42(10):859-70. PubMed ID: 9359970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA; Johnston CI
    Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.
    Melmon KL; Bourne HR; Weinstein Y; Shearer GM; Kram J; Bauminger S
    J Clin Invest; 1974 Jan; 53(1):13-21. PubMed ID: 4357609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors, adenylate cyclase, depression, and lithium.
    Belmaker RH
    Biol Psychiatry; 1981 Apr; 16(4):333-50. PubMed ID: 6261845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinction between adrenergic and serotonergic receptor subtypes: specificity of drugs and absence of cooperative interactions between adrenergic and serotonergic receptor binding sites.
    Leysen JE; Van Gompel P; Gommeren W
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S78-87. PubMed ID: 2459521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium inhibits both adenylate cyclase and high-affinity 3H-labeled p-aminoclonidine binding to alpha 2-adrenergic receptors in purified human platelet membranes.
    Mooney JJ; Horne WC; Handin RI; Schildkraut JJ; Alexander RW
    Mol Pharmacol; 1982 May; 21(3):600-8. PubMed ID: 6287197
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors acting through adenylate cyclase in the CNS.
    Wollemann M
    Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine-induced desensitization in turkey erythrocytes: cAMP mediated impairment of high affinity agonist binding without alteration in receptor number.
    Stadel JM; De Lean A; Mullikin-Kilpatrick D; Sawyer DD; Lefkowitz RJ
    J Cyclic Nucleotide Res; 1981; 7(1):37-47. PubMed ID: 6265513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
    Galant SP; Allred SJ
    J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Receptor mechanism of catecholamine and steroid action in bronchial asthma].
    Płusa T
    Pneumonol Pol; 1982 Dec; 49(12):853-6. PubMed ID: 6283483
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.